Biodesix
BDSX
41 hedge funds and large institutions have $21.4M invested in Biodesix in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 7 closing their positions.
163% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 8
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.04% less ownership
Funds ownership: 0.79% → 0.75% (-0.04%)
2% less funds holding
Funds holding: 42 → 41 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
39% less capital invested
Capital invested by funds: $34.9M → $21.4M (-$13.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Birchview Capital
Burlington,
Vermont
|
+$965K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$686K |
| 3 |
Millennium Management
New York
|
+$339K |
| 4 |
Two Sigma Investments
New York
|
+$183K |
| 5 |
CC
Chicago Capital
Chicago,
Illinois
|
+$176K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$1.49M |
| 2 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$946K |
| 3 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$786K |
| 4 |
CAM
Connacht Asset Management
New York
|
-$741K |
| 5 |
AWE
Avidian Wealth Enterprises
Houston,
Texas
|
-$411K |
BDSX Hedge Fund Activity: Q4 2021 in Review
41 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q4 2021, worth a combined $21.4M — down 39% from $34.9M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BDSX and 6 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 21 added.
The largest buyer was Birchview Capital, adding an estimated $965K. The largest seller was Oracle Investment Management, exiting entirely with an estimated $1.49M sold.
- 41 institutional investors held Biodesix (BDSX) as of Q4 2021, down from 42 in Q3 2021.
- Funds reported $21.4M of Biodesix stock for Q4 2021, down 39% quarter-over-quarter.
- 6 funds opened new Biodesix positions in Q4 2021 and 7 closed out, a net change of -1 holder.
- The largest Biodesix buyer in Q4 2021 was Birchview Capital, an estimated $965K added.
- The largest Biodesix seller in Q4 2021 was Oracle Investment Management, an estimated $1.49M sold.
Based on aggregated 13F filings for Q4 2021.